每年研究成果
每年研究成果
- 6結果
搜尋結果
-
2021
Is There Still a Role for Sulfonylureas in Type 2 Diabetes?
Tomlinson, B., Chan, P. & Lam, C. W. K., 8月 2021, 於: Current Pharmacogenomics and Personalized Medicine. 18, 2, p. 58-59 2 p.研究成果: 雜誌貢獻 › 社論 › 同行評審
-
2020
Statin Pharmacology Revisited
Tomlinson, B., Chan, P., Liu, Z. & Lam, C. W. K., 4月 1 2020, 於: Cardiovascular Drugs and Therapy. 34, 2, p. 225-226 2 p.研究成果: 雜誌貢獻 › 社論 › 同行評審
開啟存取 -
2018
Attaining cholesterol goals: will aiming for lower targets improve the score?
Leong, I. L., Tomlinson, B., Zhang, Y., Chan, P. & Liu, Z. M., 2月 1 2018, 於: Current Medical Research and Opinion. 34, 2, p. 297-299 3 p.研究成果: 雜誌貢獻 › 社論 › 同行評審
1 引文 斯高帕斯（Scopus） -
2017
The ODYSSEY DM-DYSLIPIDEMIA trial: Confirming the benefits of alirocumab in diabetic mixed dyslipidemia
Chan, P., Shao, L., Tomlinson, B. & Liu, Z. M., 12月 2017, 於: Annals of Translational Medicine. 5, 23, 477.研究成果: 雜誌貢獻 › 社論 › 同行評審
-
2016
Current status of personalized medicine based on pharmacogenetics in cardiovascular medicine
Tomlinson, B., Hu, M., Waye, M. M. Y., Chan, P. & Liu, Z. M., 1月 2 2016, 於: Expert Review of Precision Medicine and Drug Development. 1, 1, p. 5-8 4 p.研究成果: 雜誌貢獻 › 社論 › 同行評審
1 引文 斯高帕斯（Scopus） -
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes
Tomlinson, B., Hu, M., Zhang, Y., Chan, P. & Liu, Z. M., 11月 1 2016, 於: Expert Opinion on Drug Metabolism and Toxicology. 12, 11, p. 1267-1271 5 p.研究成果: 雜誌貢獻 › 社論 › 同行評審
開啟存取8 引文 斯高帕斯（Scopus）